BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 3217920)

  • 1. Decreased platelet-free dopamine and unchanged noradrenaline and adrenaline in essential hypertension.
    Kjeldsen SE; Gjesdal K; Leren P; Eide IK
    Thromb Haemost; 1988 Oct; 60(2):251-4. PubMed ID: 3217920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamine sulfates and platelet phenolsulfotransferase activity in essential hypertension.
    Kuchel O; Buu NT; Hamet P; Larochelle P; Bourque M; Genest J
    J Lab Clin Med; 1984 Aug; 104(2):238-44. PubMed ID: 6589333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension.
    Kjeldsen SE; Flaaten B; Eide I; Helgeland A; Leren P
    Scand J Clin Lab Invest; 1982 May; 42(3):217-23. PubMed ID: 7134805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium depletion increases platelet and plasma catecholamines in hypertensive men.
    Kjeldsen SE; Westheim A; Lande K; Gjesdal K; Leren P; Enger E; Eide IK
    Hypertension; 1988 May; 11(5):477-82. PubMed ID: 3366481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of free and conjugated catecholamines between plasma, platelets and erythrocytes: different effects of intravenous and oral catecholamine administrations.
    Ratge D; Kohse KP; Steegmüller U; Wisser H
    J Pharmacol Exp Ther; 1991 Apr; 257(1):232-8. PubMed ID: 2019988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma adrenaline and noradrenaline in essential and renal hypertension (author's transl)].
    Skrabal F; Auböck J; Hörtnagl H; von Brücke T
    Wien Klin Wochenschr; 1981 May; 93(10):321-5. PubMed ID: 7020260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet alpha 2-adrenoceptors and diurnal changes of platelet aggregability in hypertensive patients.
    Mores N; Martire M; Pistritto G; Volpe AR; Menini E; Folli G; Cardillo C
    J Hypertens; 1994 Aug; 12(8):939-45. PubMed ID: 7814853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased platelet size and release reaction in essential hypertension.
    Lande K; Os I; Kjeldsen SE; Westheim A; Hjermann I; Eide I; Gjesdal K
    J Hypertens; 1987 Aug; 5(4):401-6. PubMed ID: 2959720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased arterial catecholamine concentrations in 50-year-old men with essential hypertension.
    Kjeldsen SE; Eide I; Aakesson I; Leren P
    Scand J Clin Lab Invest; 1983 Jun; 43(4):343-9. PubMed ID: 6635541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma catecholamines and production of thromboxane B2 by platelets after psychological and physical tests in normotensive and mild hypertensive subjects.
    Vapaatalo H; Tuomisto M; Turjanmaa V; Metsä-Ketelä T; Fredrikson M; Uusitalo A
    Biomed Biochim Acta; 1988; 47(10-11):S294-8. PubMed ID: 3248115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alpha 2-adrenergic receptors and arterial pressure].
    Senard JM; Valet P; Galinier M; Tran MA; Galinier F; Boneu B; Montastruc JL
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1139-41. PubMed ID: 2554834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma noradrenaline during severe sodium restriction does not stimulate platelet release in essential hypertension.
    Kjeldsen SE; Lande K; Gjesdal K; Jackson MB; Westheim A; Frederichsen P; Leren P; Eide I
    Thromb Haemost; 1986 Oct; 56(2):120-3. PubMed ID: 2949387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma catecholamines and adrenoceptors in young hypertensive patients.
    Müller R; Steffen HM; Weller P; Krone W
    J Hum Hypertens; 1994 May; 8(5):351-5. PubMed ID: 8064782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of platelet catecholamine content for the diagnosis of pheochromocytoma with intermittent hypertension].
    Plouin PF; Chatellier G; Billaud-Mesguich E; Comoy E; Duclos JM; Ménard J
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):812-5. PubMed ID: 3116976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arterial hypertension. Density of alpha 1 and alpha 2 adrenergic receptors in blood platelets, beta adrenergic receptors in the lymphocytes and serum catecholamine levels].
    Halawa B
    Kardiol Pol; 1991; 35(12):340-4. PubMed ID: 1666134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of body weight on plasma catecholamine patterns in middle-aged, normotensive men.
    Kjeldsen SE; Eide I; Aakesson I; Leren P
    Scand J Clin Lab Invest; 1983 Jun; 43(4):339-42. PubMed ID: 6635540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Catecholamine levels in plasma and cerebrospinal fluid of neurosurgical patients with normal and elevated intracranial pressure].
    Rudolph C; Schaffranietz L; Jaeger M; Vetter B; Meixensberger J; Olthoff D
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Oct; 39(10):603-9. PubMed ID: 15486803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sampling site and conditions on plasma levels of noradrenaline, adrenaline and dopamine.
    Saar N; Jackson R; Bachmann A; Gordon R
    Prog Biochem Pharmacol; 1980; 17():90-7. PubMed ID: 7208507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of street noise on blood catecholamines, cyclic AMP and various cardiovascular and metabolic functions in a group of subjects with untreated essential hypertension].
    Catapano F; Portaleone P; Ferretti C; Fornaca GF; Liberali L; Giuliani GC; Verdun di Cantogno L
    Minerva Med; 1984 Oct; 75(40):2361-7. PubMed ID: 6095140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.